π¬Deep Research
CUPR β Cuprina Holdings (Cayman) Ltd Β· catalysts, narrative & risks
Cuprina Holdings (Cayman) Ltd (CUPR) β Research Snapshot (as of 2026-10-23)
Company context. Cuprina is a Singapore-based biomedical/biotechnology company developing and commercializing wound-care products (under the MEDIFLY brand) as well as operating in infertility, medical waste recycling, and cosmeceuticals/travel healthcare. It trades on Nasdaq Capital Market under "CUPR" [1][2][19]. The most recent reported closing price was ~$1.88 on October 22, 2026, with a market capitalization in the range of ~$13.17Mβ$14.08M (sources vary slightly, e.g., [16][18][19] vs. the ~$14.08M figure noted in our background data).
1. Key Recent Catalysts (roughly JulyβOctober 2026)
AI-assisted research from the K3vl4r desk β not personalized investment advice. More research β